Similar Posts
FDA Squelches an Article Raising Doubts on Safety Of Device to Repair Artery – WSJ
FDA Squelches an Article Raising Doubts on Safety Of Device to Repair Artery – WSJ Fri, 9 Jul 2004 A front page article in The Wall Street Journal exposes another case of safety data suppression by the FDA. The case involves a device to repair the heart artery which FDA’s…
FDA Foot Dragging – Three Months After Expert Panel Urged "Black Box" Warnings for Antidepressants, No Action
FDA Foot Dragging – Three Months After Expert Panel Urged “Black Box” Warnings for Antidepressants, No Action Thu, 23 Dec 2004 Why is the FDA failing to enforce the "Black Box" warnings on SSRI antidepressant drug labels? When questioned by the NJ Star Ledger, Robert Temple, director of the FDA’s…
Former President of Amer Heart Assoc Caught in Fraud – BMJ
Former President of Amer Heart Assoc Caught in Fraud – BMJ December 14, 2002 The British Medical Journal reports about the FDA took action against American cardiologist Dr. David Faxon, immediate past president of the American Heart Association for medical ethics violations, such as: falsification of data, false claims about…
Doctors On the Take-Engaging in Vairous Dubious Activities for Cash / Stock Options
Doctors On the Take-Engaging in Vairous Dubious Activities for Cash / Stock Options Tue, 16 Aug 2005 A series of current articles in The Wall Street Journal, the Journal of the American Medical Association (JAMA), and the New York Times describe the many questionable non-medical income-producing activities that America¹s physicians…
VA administrators attempt to scuttle legislation to protect patients
VA administrators attempt to scuttle legislation to protect patients Wed, 30 Apr 2003 The Alliance for Human Research Protection received the following confidential Veterans Affairs communication describing efforts by VA administrators to scuttle a congressional bill whose aim is to ensure that research conducted at VA facilities is overseen by…
Former FDA Commissioner says FDA lost public trust
Former FDA Commissioner says FDA lost public trust Mon, 17 Oct 2005 The FDA’s failure to ensure drugs are properly tested in trials designed to detect serious adverse effects, and the agency’s failure to require follow-up post-marketing studies to be reasonably secure in the knowledge that no lethal drugs are unleashed on the public has…